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We have investigated the effect of pH on LDL oxidation by macrophages (in the presence of iron ions), using a m~ifi~t~on of Hanks’ balanced 
salt solution, Increasing the acidity of the medium greatly increased the oxidation of the LDL by the macrophages as measured by thiobarbituric 
acid-reactive substances or increased uptake and degradation by a second set of macrophages. The rate of oxidation of LDL by iron ions alone, 
measured in terms of conjugated ienes, was also increased greatfy even at mildly acidic pH. It is quite possible that atherosclerotic lesions have 
an acidic extracellular pH, particularly in the vicinity of macrophages, and the observation that LDL oxidation by macrophages i  increased at 
acidic pH may therefore help to explain why atherosclerotic lesions are apparently one of the very few sites in the body where LDL oxidation occurs. 
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1. INTRODUCTION 
Atherosclerotic lesions are often characterised by the 
presence of large number of foam cells filled with lipid 
droplets consisting largely of cholesteryl esters. Many 
of these foam cells are derived from macrophages [l-4]. 
Macrophages in culture take up low density lipoprotein 
(LDL) only slowly via their LDL receptors, which are 
present in relatively small nmbers [SJ, but they take up 
oxidised LDL rapidly by means of their scavanger e- 
ceptor(s) [6]. 
scribed elsewhere 1141 and ra~ola~ll~ with Na”‘I using iodine mono- 
chloride [lo]. 
2.2. Mod@cation of LDL by cells 
LDL can be oxidised in vitro under appropriate con- 
ditions by a number of cell types including endothelial 
cells [7], smooth muscle cells [SJ, macrophages [9, lo] and 
lymphocytes [1 I] or by auto-oxidation catalysed by cop- 
per [ 12,131 or iron [lo] ions in the absence of cells. 
Consequently, any relevant factor influencing this oxi- 
dative modification may play a potential role in the 
development of atherosclerosis. In this study, we have 
investigated the effect of pH on ill-rn~iat~ LDL ox- 
idation or LDL oxidation mediated by iron ions. 
Resident macrophages were isolated by peritoneal lavage of female 
Swiss T.O. mice (B-30 g) (A. Tuck and Son, Battlesbridge, Essex, UK) 
as described elsewhere [lo]. ‘251-labelled LDL (1OOpg protein/ml) was 
incubated with intact macrophages (1 x lo6 peritoneal cells/well (22 
mm multiwell dishes, Costar}) or cell-free wells for 18 h at 37’C in 
triplicate at the indicated pH value in modified Hanks’ balanced salt 
solution (HBSS) (10 mM Na,HPO, or 10 mM KH,PO, was added to 
stock solutions of 1.26 mM CaCl,, 0.81 mM MgSO,, 5.36 mM KCl, 
113 mM NaCl and 5.55 mM glucose, and then these two solutions 
mixed together to give the desired pH) supplemented with 6pM FeSO, 
(1 ml per well). At the end of the incubations, viability of the cells was 
assessed by viewing under a phase-contrast microscope and by ceilular 
protein estimations. 
2.3. Determination of oxidised LDL degradation by macrophages 
2. MATERIALS AND METHODS 
2.1. Isolation and radioiodination of LDL 
LDL (1 .O l P-1.063 g/ml) was isolated from normal human blood by 
sequential density ~tra~nt~fu~tion in KBr solutions at 4*C as de- 
Modified or control ‘ZsI-labelled LDL was diluted to 10 pug protein/ 
ml in DMEM containing 10% (v/v) foetal calf serum and 50 #g gen- 
tamicin/ml. (The pH of the DMEM/serum medium under 5% CO, was 
not affected by the addition of the modiied HBSS of various pHs, 
when added in a ratio of 1 vol. of HBSS to 9 ~01s. of DMEM/serum.) 
It was then incubated for a further 22 h with a second set of macro- 
phages or cell-free wells with 1 ml per well. The radioactive noniodide, 
t~chloroaceti~ acid-soluble degradation products released into the 
medium were measured as described previously [lo]. Degradation 
products in the cell-free wells were subtracted from those in the wells 
containing macrophages. The cells were washed in PBS containing 
Ca*+ and MgZ’, lysed in 0.2 M NaOH as described elsewhere [lo] and 
assayed for protein by a modiied Lowry procedure [IQ 
*Corresponding author. Fax: (44) (734) 310 180. 2.4. Thio~bitutic acid-reactive ~stances assay [i6] 
Abbreviations: DMEM, Dulbecco’s Modified Eagle’s Medium; LDL, 
low density lipoprotein; PBS, phosphate buffered saline; HBSS, 
Hanks’ balanced salt solution; MDA, m~o~dialdehyde; EDTA, eth- 
ylen~aminetetra-attic acid; TBARS, thiobarbitu~c acid-reactive 
substances. 
Samples of modified or control LDL (250 ~1 of 100 @g proteinfml) 
were taken and 3 ml of 0.335% (w/v) thiobarbituric acid in 10% (w/v) 
trichloroacetic acid was added to each sample and incubated at 95°C 
for 15 min. The absorbance was read at 535 nm. Standards of tetrame- 
thoxypropane (Sigma), up to 5 trmol per tube, were prepared in mod- 
ified HBSS @H 7.4). 
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Fig. 1. ‘Z51-labelled LDL (1OOpg protei~ml) was incubated for 18 h in triplicate at the indicated pH value with intact macrophages (macrophage- 
modified LDL) or in cell-free wells (control LDL) in modified Hanks’ balanced salt solution supplemented with 6 ,uM FeSO,. Modified or control 
LDL was diluted to 10 @g protein/ml in Dulbecco’s modified Eagle’s medium containing 10% (v/v) foetal calf serum and 50 pg gentamicin/ml and 
incubated with a second set of macrophages or cell-free wells for 22 h and its rate of degradation measured. The mean + S.E.M. (n = 3) are shown. 
The results shown are representative of 3 independent experiments. 
2.5. Iron-mediated oxidation of LDL 
‘*SI-labelled LDL was dialysed against several changes of saline/ 
phosphate buffer (pH 7.4) at 4°C to remove EDTA and its radioactiv- 
ity was determined and its con~ntration adjusted to 5Opg protein/ml. 
It was then oxidised using 50 PM FeSO, at pH 7.4, 7.0, 6.5 or 5.5 in 
the modified HBSS at ambient emperature and monitored at 234 nm 
in a spectrophotometer [13]. 
3. RESULTS 
By an adaptation of Hanks’ balanced salt solution, 
we were able to maintain macrophages in a viable state 
over a wide pH range and study the effect of pH on 
cell-mediated oxidation of LDL, as measured by an 
increased rate of uptake and degradation by a second 
set of macrophages at pH 7.4. At all pH values, the 
macrophages had a normal appearance when viewed 
under the phase-contrast microscope and yielded simi- 
lar cell protein contents when assayed at the end of the 
incubation (results not shown). Fig. 1 shows one exper- 
iment in which there was no LDL oxidation by macro- 
phages at pH 7.4 but a progressive increase in oxidation 
as the PI-I was decreased with a pH optimum of 5.5. At 
this pH, there was a 6-fold increase in LDL modifica- 
tion relative to the control LDL (LDL incubated in 
cell-free dishes). The oxidation of the control LDL, 
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probably due to the iron ions added to the modified 
HBSS, was also increased progressively at acidic pH, 
but to a more limited extent and with no evidence for 
an optimum pH over the pH range tested. 
The modification of the LDL by macrophages at 
acidic pH was due to its oxidation, as shown by an 
increase in the levels in the medium of thiobarbituric 
acid-reactive substances (TBARS), products of lipid ox- 
idation (Table I). Due to the necessity for transition 
metal ions to catalyse the oxidation of LDL, when 
FeSO, was excluded from the incubation medium little 
increase in TBARS or degradation by macrophages was 
observed in the macrophage-modified LDL compared 
to the control LDL. When 6 ,uM FeSO, was added, the 
TBARS and macrophage degradation increased for 
both the macrophage-modified LDL and control LDL, 
but the increases were greater for the ma~rophage-mod- 
ified LDL. Further evidence that the modification proc- 
ess at acidic pH was an oxidative one was that the 
presence of the lipophilic antioxidant butylated hy- 
droxytoluene (BHT) during exposure of the LDL to the 
modifying macrophages blocked the changes een in the 
TBARS and in the degradation by a second set of mac- 
rophages (Table I). The addition of 20 ,uM polyinosinic 
acid (a competing ligand for the scavenger eceptor) 
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‘251-Labelled LDL degradation by macrophages TBARS 
@g LDL proteinlmg cell protein in 16 h) (nmol MDA/mg LDL protein) 
macrophage-modified LDL control LDL macrophage-modified LDL control LDL 
No addition 0.73 + 0.04 0.67 2 0.06 5.0 f 1.0 2.0 * 0.0 
6yM FeSO, 2.39 r 0.24 1.34 t 0.08 29.0 i 2.4 13.0 f 2.7 
6 PM FeSO, + 20 PM BHT 0.60 z!z 0.04 0.66 zb 0.21 4.0 + 0.0 4.0 + 0.0 
‘251-labelled LDL (100 pg protein/ml) was incubated for 24 h with macrophages (1 x lo6 peritoneal cells/22 mm multiwell dish) or cell-free wells 
(control) in a modified Hanks’ balanced salt solution at pH 5.5 with or without 6 PM FeSO, or 20 PM butylated hydroxytoluene (BHT). It was 
then assayed for MDA or MDA-like products by a TBARS assay or was diluted to 10 fig protein/ml in Dulbecco’s modified Eagle’s medium 
containing 10% (v/v) foetal calf serum and 50 pg gent~ici~ml and added to a second set of macrophages or cell-free wells and incubated for 16 
h and its rate of degradation measured. The mean + S.E.M. for 3 wells are shown. Another independent experiment gave similar results. 
resulted in an 88% inhibition of the degradation by 
macrophages of LDL modified by macrophages at 
acidic pH (data not shown). 
The formation of conjugated dienes was used as a 
measure of LDL oxidation by iron ions, in the absence 
of cells. LDL oxidation by iron ions alone in HBSS 
measured in this way was very slow at pH 7.4 (Fig. 2). 
The formation of conjugated dienes after the lag phase 
was much greater at pH 7.0 than at pH 7.4; at pH 6.5 
it was greater still and with a shorter lag phase. It was 
much less, however, at pH 5.5 than at pH 6.5. (A similar 






phosphate-based buffer was used.) The observed 
changes in absorbance were not an artefact due to an 
effect of pH on the molar absorption coefficient of con- 
jugated dienes as this was unchanged over the pH range 
7.4-5.5 (results not shown). 
4. DISCUSSION 
By an adaption of HBSS, we were able to study the 
effect of pH on both cell-mediated and metal ion-cataly- 
sed oxidation of LDL. Increasing the acidity of the 
medium greatly increased the oxidation of LDL by the 
pH 7.4 
- pH 7.0 
- pH 6.5 
- pH 5.5 
0 60 120 180 240 
Time (minutes) 
Fig. 2. Effect of pH on the oxidation of LDL by iron ions as measured by conjugated iene absorbance. Following dialysis to remove any EDTA, 
the LDL (50 pug protein/ml) was oxidised using 50 PM FeSO, at pH 7.4 (a)), 7.0 (+), 6.5 (f) or 5.5 (0) in a modified Hanks’ balanced salt solution 
at ambient emperature and monitored at 234 nm in a spectrophotometer. The results shown are representative of 5 independent experiments. 
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macrophages as measured by TBARS or macrophage 
degradation. A similar effect of pH was also seen when 
iron ions alone were used to catalyse the oxidation of 
LDL as measured by an increase in conjugated diene 
formation at pH 6.5 and 7.0 compared to 7.4. (When 
LDL was oxidised by copper ions alone, however, there 
was a large decrease in conjugated diene formation at 
acidic PH.) 
There are many possibilities to explain why LDL 
oxidation by macrophages was increased by acidic PH. 
The macrophages may possibly produce more free rad- 
icals or oxidised lipids at acidic pH. Any superoxide 
anion produced by them would be converted more to 
hydroperoxyl radicals (which have a pKa of 4.8) and it 
is known that hydroperoxyl radicals generated by 
steady-state radiolysis are much more active in oxidis- 
ing the lipids of LDL than superoxide anions are [ 171. 
The dismutation of superoxide to H,Oz is more rapid 
at acidic pH [18] and if H,O, and superoxide react to- 
gether in a metal-catalysed Haber-Weiss reaction to 
form the highly reactive hydroxyl radical, this could 
conceivably help to explain why LDL oxidation by cells 
is faster at acidic pH. Another possibility is that the 
cellular reIease or extracellular oxidation of thiols, 
which may be involved in LDL oxidation [19], may be 
increased at acidic pH. Other possibilities to explain 
why macrophages or iron ions alone oxidise LDL faster 
at acidic pH are that the chain reaction of lipid peroxi- 
dation, the ability of iron ions to redox cycle, the solu- 
bility of ferric ions, the fra~entation of lipid hydroper- 
oxides to produce aldehydes or the reaction of alde- 
hydes with apolipoprotein B-100 may be increased at 
acidic pH. 
It appears that the oxidation of LDL occurs in the 
arterial wall and not in the general circulation, as LDL 
oxidation is inhibited strongly by plasma [lo]. Conse- 
quently, LDL oxidation may require the sequestered 
microenvironment present within atherosclerotic le- 
sions, where the ratio of oxidative stress to antioxidants 
may be high and where the extracellular pH may be 
acidic. It is becoming increasingly clear that atheroscle- 
rotic lesions are analogous in many ways to chronic 
inflammatory sites. The extracellular pH has been 
known for a long time to be low in infla~atory sites 
[20]. In addition, atherosclerotic lesions are known to 
be ischaemic [21,22] and this may mean that cells in the 
lesions rely to a large extent on glycolysis for their en- 
ergy production and thus produce a lot of lactic acid 
which may diffuse away only slowly due to the poor 
perfusion of atherosclerotic lesions and may thus acid- 
ify the extracellular space. The pH of the interstitial 
space of the ischaemic brain in hyperglycaemic rats has 
been shown to be 6.2 [23] and the extracellular pH of 
tumours (which are poorly perfused) in hyperglycaemic 
rats can be as low as 5.2 [24]. Macrophages extrude H+ 
in part by a H’-ATPase in the plasma membrane and 
in weakly buffered medium they can acidify their ex- 
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tracellular pH from 7.4-7.2 to 6.5 in only 25 min and 
it may well fall even more given longer [ZS]. Atheroscle- 
rotic lesions contain macrophages that have some of the 
characteristics of activated macrophages [26] and the 
pH near to the surface of activated macrophages is 
known to be as low as 3.6 [27]. Thus LDL oxidation 
may occur in microdomains of high oxidative stress 
near the surface of macrophages where the pH may be 
low. 
The finding that LDL oxidation by macrophages 
takes place faster at acidic pH may help to explain why 
atherosclerotic lesions are apparently one of the very 
few sites in the body where LDL oxidation proceeds to 
a significant degree. 
~e~o~ledge~nrs: We are grateful to Mr. Justin P. Richards for 
dedicated technical assistance. We would also like to acknowledge Dr. 
Gary M. Wilkins and Miss Jo-anne E. Robson and Miss Paula A. 
Messam for carrying out some of the preliminary studies on the effect 
of pH on the oxidation of LDL by copper or iron in the absence of 
cells. We would also like to thank the Medical Research Council for 
financial support. 
REFERENCES 
[I] Fowler, S., Shio, H. and Haley, N.J. (1979) Lab. Invest. 41, 
312-348. 
[2] Schaffner, T., Taylor, K., Bartucci, E.J., Fischer-Dzoga, K., 
Bennson, J.H., Glagow, S. and Wissler, R. (1980) Am. J. Pathol. 
100, 57-80. 
[3] Gerrity, R.G. (1981) Am. J. Pathol. 103, 181-190. 
[4] Aqel, N.M., Ball, R.V., Waldmann, H. and Mitchinson, M.J. 
(1984) Atherosclerosis 53, 265-271. 
[5] Koo, C., Wernette-Hammond, M.E. and Innerarity, T.L. (1986) 
J. Biol. Chem. 261, 1119411201. 
[6] Wit-&urn, J.L. and Steinberg, D. (1991) J. Clin. Invest. 88, 178% 
1792. 
[7j Henriksen, T., Maloney, E.M. and Steinberg, D. (1981) Proc. 
Natl. Acad. Sci. USA 78, 6499-6503. 
[8] Henriksen, T., Maloney, E.M. and Steinberg, D. (1983) Arterio- 
sclerosis 3, 1455159. 
[9] Parthasarathy, S., Printz, D.J., Boyd, D., Joy, L. and Steinberg, 
D. (1986) Arteriosclerosis 6, 50.5-510. 
[lo] Leake, D.S. and Rankin, S.M. (1990) B&hem. J. 270,741-748. 
[11] Lamb, D.J., Wilkins, G.M. and Leake, D.S. (1992) Atherosclero- 
sis 92, 187-192. 
[12] Steinbrecher, U.P., Parthasarathy, S., Leake, D.S., Witztum, J.L. 
and Steinberg, D. (1984) Proc. Natl. Acad. Sci. 81, 3883-3887. 
[13] Esterbauer, H., Striegl, G., Puhl, H. and Rotteneder, M. (1989) 
Free Rad. Res. Comm. 6, 67-75. 
[14] Rankin, S.M., Knowles, M.E. and Leake, D.S. (1989) Athero- 
sclerosis 79, 71-78. 
[IS] Schacterie, G.R. and Pollak, R.L. (1973) Anal. Biochem. 51, 
654655. 
[16] Bemheim, F., Brenheim, M.L.C. and Wilbur, KM. (1948) J. 
Biol. Chem. 174,257-264. 
[17] Bedwell, S., Dean, R.T. and Jessup, W. (1989) B&hem. J. 262, 
707-712. 
[18] Halliwell, B. and Gutteridge, J.M.C. (1985) Free Radicals in 
Biology and Medicine, Clarendon Press, Oxford, pp. 73-74. 
1191 Heinecke, J.W., Rosen, H., Suzuki, L.A. and Chait, A. (1987) J. 
Biol. Chem. 262, 1098-l 100. 
[20] Menkin, V. (1934) Am. J. Pathol. 10, 193-210. 
[21] Zemplenyi, T. (1968) Enzyme Biochemistry of the Arterial Wall, 
Lloyd-Luke, London. 
Volume 333, number 3 FEBS LETTERS November 1993 
[22] Hajjar, D.P., Farber, I.C. and Smith, S.C. (1988) Arch. Biochem. 
Biophys. 262, 375-380. 
[23] Kraig, R.P. and Chester, M. (1990) J. Cereb. Blood Flow Metab. 
10, 104114. 
[24] Jahde, E. and Rajewski, M.F. (1982) Cancer Res. 42, 1505-1512. 
[25] Tapper, H. and Sundler, R. (1992) Biochem. J. 281, 245-250. 
[26] Munro, J.M., Van Der Walt, J.D., Munro, C.S., Chahner, J.A.C. 
and Cox, E.L. (1987) Hum. Pathol. 18, 375380. 
[27] Silver, LA., Murrils, R.J. and Etherington, D.J. (1988) Exp. Cell. 
Res. 175, 266267. 
279 
